Premjit Singh Chahal, MD
Gastroenterology · Pleasant Hill
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
- Since medical school
- 26 years
- Virginia Commonwealth University, School of Medicine, 2000
Offices
1 location · Diablo Digestive Care, Inc. · 2 clinicians in this group
Looking this up.
Hospitals listed: John Muir Medical Center - Concord Campus. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chahal’s office at (925) 363-0069 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A78375 · Current
Licensed to practise in California · since 2002 · expires 2027-05-31 · Virginia Commonwealth University, Medical College of Virginia.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Diablo Plaza Surgery Center, LP dba Diablo Plaza Surgery CenterAmbulatory Surgery Center · Concord, CA20% owner since 2019 · accredited by AAAHCAccreditation Renewed4 inspections, 1 with deficiencies · last 2024-10-03
- East Bay Endoscopy CenterAmbulatory Surgery Center · Emeryville, CAOwner · accredited by JCInitial AccreditationNo inspections published
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- John Muir Medical Center - Concord CampusConcord, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of John Muir Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.235, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.675, Oct 2024 – Sep 2025
See every measure and the patient survey for John Muir Medical Center - Concord Campus
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.235 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.675 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.11 (0.21 to 2) · 1,612 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.77 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 184.13 (136.65 to 231.6) · 86 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.2 · 175 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.6 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.4 · 172 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8 · 537 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.5 · 434 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13 · 215 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,208 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.32 (0.13 to 0.51) · 7,626 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,660 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.1 (1.29 to 4.91) · 2,723 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.21 (0 to 2.51) · 1,208 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3 (1.7 to 4.3) · 2,355 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.77 (3.24 to 12.3) · 1,216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.43 (0.43 to 6.43) · 1,253 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.93 (0.47 to 3.4) · 388 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.14 (0.58 to 1.69) · 6,288 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 263 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.636 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.254 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.904 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.5 · 312 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.1 · 768 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -6.8 · 295 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.1 · 648 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 31.1 · 433 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 504 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.7 (5.1 to 8.8) · 476 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.9 (10.5 to 15.7) · 476 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 8.8 · 154 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.7 · 186 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (9.9 to 17.9) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.2) · 546 cases | No different | Jan 2024 – Dec 2024 |
What patients said (521 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$223,039
Medicare paid this office $223,039 for 624 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 316 | $60,044 | $184 |
| Removal of large bowel tissue using a flexible endoscope | 116 | $36,818 | $315 |
| Return visit (30+ min) | 228 | $29,209 | $102 |
| New patient visit (45+ min) | 215 | $29,099 | $135 |
| Biopsy of small bowel (except ileum) using an endoscope | 154 | $20,240 | $121 |
See all 11 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 316 | $60,044 | $184 |
| Removal of large bowel tissue using a flexible endoscope | 116 | $36,818 | $315 |
| Return visit (30+ min) | 228 | $29,209 | $102 |
| New patient visit (45+ min) | 215 | $29,099 | $135 |
| Biopsy of small bowel (except ileum) using an endoscope | 154 | $20,240 | $121 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 158 | $10,680 | $62 |
| Removal of external hemorrhoids by rubber banding | 37 | $9,754 | $150 |
| Biopsy of large bowel using a flexible endoscope | 224 | $7,469 | $33 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 35 | $5,358 | $79 |
| Short return visit (20+ min) | 66 | $5,079 | $76 |
| New patient visit (30+ min) | 46 | $4,328 | $94 |
Procedures Medicare counted
| Colonoscopy | 53 | More than 65% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 168 | More than 87% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Biopsy of large bowel using a flexible endoscope | 259 | 244 | 287 | 257 | 230 | 229 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 97 | 196 | 276 | 244 | 257 | 326 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 209 | 158 | 178 | 184 | 165 | 172 |
| Biopsy of small bowel (except ileum) using an endoscope | 195 | 158 | 159 | 181 | 157 | 167 |
| Removal of external hemorrhoids by rubber banding | 63 | 83 | 75 | 82 | 79 | 65 |
| Removal of large bowel tissue using a flexible endoscope | – | – | – | 105 | 198 | 117 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
624 Original Medicare patients in 2024. Average age 73 · Under 65 10% · 85 and older 9% · Women 52% · Also on Medicaid 24% · Health risk score 1.08. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 69% · Diabetes 28% · Chronic kidney disease 18% · Coronary heart disease 17% · Depression 17% · Atrial fibrillation 16% · Cancer 15% · COPD 13% · Heart failure 9% · Stroke 7% · Dementia 3%.
The office billed $1,813,349, Medicare allowed $281,225 and paid $223,039; for 1,783 services of 20 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 624 | 1,783 | 73 | 1.08 | $1,813,349 | $223,039 |
| 2023 | 531 | 1,739 | 73 | 1.15 | $1,746,370 | $207,604 |
| 2022 | 527 | 1,757 | 73 | 1.15 | $1,437,835 | $194,236 |
| 2021 | 531 | 1,747 | 73 | 1.06 | $1,349,048 | $188,478 |
| 2020 | 475 | 1,621 | 73 | 1.10 | $1,178,485 | $165,167 |
| 2019 | 586 | 1,945 | 73 | 1.15 | $1,236,312 | $197,087 |
| 2018 | 599 | 2,041 | 73 | 1.14 | $1,401,626 | $215,374 |
| 2017 | 601 | 1,776 | 73 | 1.08 | $1,165,338 | $194,071 |
| 2016 | 532 | 1,931 | 72 | 1.05 | $1,224,849 | $222,668 |
| 2015 | 519 | 1,903 | 72 | 1.08 | $1,128,728 | $216,826 |
| 2014 | 465 | 1,900 | 72 | 1.02 | $1,161,496 | $233,024 |
| 2013 | 329 | 1,087 | 72 | 1.05 | $504,634 | $176,621 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Removal of large bowel tissue using a flexible endoscope | 198 | $59,561 | $301 |
| Return visit (30+ min) | 213 | $30,583 | $103 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 255 | $28,502 | $111 |
| New patient visit (45+ min) | 198 | $26,267 | $133 |
| Biopsy of small bowel (except ileum) using an endoscope | 138 | $18,785 | $120 |
| Removal of external hemorrhoids by rubber banding | 37 | $12,558 | $159 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 143 | $9,376 | $57 |
| Biopsy of large bowel using a flexible endoscope | 226 | $7,394 | $32 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 32 | $4,866 | $85 |
| Short return visit (20+ min) | 44 | $3,337 | $73 |
| New patient visit (30+ min) | 34 | $2,857 | $84 |
2022: 11 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 238 | $41,980 | $172 |
| Removal of large bowel tissue using a flexible endoscope | 105 | $29,636 | $282 |
| Return visit (30+ min) | 202 | $29,188 | $105 |
| New patient visit (45+ min) | 175 | $23,099 | $132 |
| Biopsy of small bowel (except ileum) using an endoscope | 156 | $22,558 | $125 |
| Removal of external hemorrhoids by rubber banding | 38 | $12,378 | $151 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 160 | $10,787 | $59 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 42 | $7,217 | $94 |
| Short return visit (20+ min) | 79 | $7,129 | $75 |
| New patient visit (30+ min) | 59 | $4,511 | $76 |
| Biopsy of large bowel using a flexible endoscope | 252 | $3,960 | $15 |
2021: 10 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 269 | $61,053 | $221 |
| Return visit (30+ min) | 204 | $32,280 | $111 |
| Biopsy of small bowel (except ileum) using an endoscope | 136 | $20,236 | $127 |
| New patient visit (45+ min) | 134 | $17,698 | $132 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 151 | $11,779 | $66 |
| Removal of external hemorrhoids by rubber banding | 36 | $11,766 | $157 |
| Short return visit (20+ min) | 127 | $10,663 | $69 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 39 | $8,765 | $90 |
| New patient visit (30+ min) | 83 | $6,796 | $82 |
| Biopsy of large bowel using a flexible endoscope | 281 | $5,765 | $20 |
2020: 10 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 191 | $44,194 | $225 |
| Return visit (30+ min) | 196 | $26,949 | $90 |
| Biopsy of small bowel (except ileum) using an endoscope | 124 | $17,842 | $113 |
| New patient visit (45+ min) | 116 | $14,719 | $127 |
| Removal of external hemorrhoids by rubber banding | 40 | $12,785 | $154 |
| Biopsy of large bowel using a flexible endoscope | 236 | $11,278 | $46 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 41 | $10,476 | $75 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 124 | $9,884 | $63 |
| Short return visit (20+ min) | 104 | $7,440 | $62 |
| New patient visit (30+ min) | 85 | $6,926 | $81 |
2019: 10 services
| Return visit (30+ min) | 266 | $33,459 | $90 |
| Biopsy of large bowel using a flexible endoscope | 256 | $30,034 | $116 |
| New patient visit (45+ min) | 198 | $26,788 | $135 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 96 | $21,688 | $224 |
| Biopsy of small bowel (except ileum) using an endoscope | 178 | $20,790 | $107 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 77 | $20,303 | $72 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 183 | $13,574 | $65 |
| Removal of external hemorrhoids by rubber banding | 36 | $9,488 | $151 |
| New patient visit (30+ min) | 104 | $9,054 | $87 |
| Short return visit (20+ min) | 114 | $8,420 | $61 |
2018: 10 services
| Return visit (30+ min) | 317 | $41,515 | $90 |
| Biopsy of large bowel using a flexible endoscope | 302 | $34,555 | $114 |
| New patient visit (45+ min) | 222 | $29,968 | $135 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 113 | $24,697 | $215 |
| Biopsy of small bowel (except ileum) using an endoscope | 192 | $20,027 | $96 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 64 | $14,281 | $70 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 198 | $13,478 | $61 |
| Removal of external hemorrhoids by rubber banding | 46 | $13,129 | $141 |
| New patient visit (30+ min) | 97 | $7,569 | $78 |
| Short return visit (20+ min) | 49 | $3,129 | $59 |
2017: 11 services
| Return visit (30+ min) | 311 | $36,632 | $84 |
| Biopsy of large bowel using a flexible endoscope | 256 | $32,084 | $124 |
| New patient visit (45+ min) | 255 | $31,666 | $124 |
| Biopsy of small bowel (except ileum) using an endoscope | 182 | $18,286 | $93 |
| Imaging of digestive tract done from the inside of the digestive tract | 21 | $16,805 | $800 |
| Removal of external hemorrhoids by rubber banding | 61 | $15,900 | $138 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 64 | $12,915 | $199 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 68 | $10,947 | $67 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 108 | $7,137 | $63 |
| New patient visit (30+ min) | 90 | $6,307 | $70 |
| Short return visit (20+ min) | 28 | $1,917 | $62 |
2016: 11 services
| Return visit (30+ min) | 286 | $37,650 | $88 |
| Biopsy of large bowel using a flexible endoscope | 245 | $29,665 | $119 |
| Imaging of digestive tract done from the inside of the digestive tract | 35 | $28,314 | $809 |
| New patient visit (45+ min) | 206 | $26,516 | $129 |
| Removal of external hemorrhoids by rubber banding | 62 | $18,426 | $147 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 77 | $16,612 | $210 |
| Biopsy of small bowel (except ileum) using an endoscope | 173 | $16,297 | $92 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 82 | $14,950 | $71 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 182 | $11,871 | $62 |
| New patient visit (30+ min) | 103 | $7,460 | $72 |
| Short return visit (20+ min) | 47 | $2,776 | $53 |
2015: 12 services
| Biopsy of large bowel using a flexible endoscope | 234 | $38,437 | $162 |
| Return visit (30+ min) | 227 | $29,449 | $88 |
| New patient visit (45+ min) | 186 | $23,850 | $128 |
| Removal of external hemorrhoids by rubber banding | 68 | $21,456 | $150 |
| Imaging of digestive tract done from the inside of the digestive tract | 21 | $17,230 | $820 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 79 | $17,190 | $74 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 67 | $16,126 | $241 |
| Biopsy of small bowel (except ileum) using an endoscope | 173 | $15,992 | $91 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 179 | $12,037 | $64 |
| Short return visit (20+ min) | 127 | $8,851 | $56 |
| New patient visit (30+ min) | 98 | $7,771 | $79 |
| New patient visit (15+ min) | 15 | $856 | $57 |
2014: 15 services
| Biopsy of large bowel using a flexible endoscope | 228 | $36,734 | $160 |
| New patient visit (45+ min) | 258 | $32,963 | $128 |
| Imaging of digestive tract done from the inside of the digestive tract | 29 | $24,582 | $819 |
| Return visit (30+ min) | 198 | $23,516 | $88 |
| Removal of external hemorrhoids by rubber banding | 55 | $17,892 | $154 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 78 | $16,134 | $76 |
| Biopsy of small bowel (except ileum) using an endoscope | 150 | $14,686 | $94 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 57 | $14,444 | $249 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 173 | $11,451 | $63 |
| Short return visit (20+ min) | 147 | $11,108 | $61 |
| Destruction of internal hemorrhoids using heat | 23 | $8,072 | $168 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 16 | $4,856 | $303 |
| New patient visit (30+ min) | 59 | $4,717 | $80 |
| Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | 12 | $2,117 | $176 |
| Biopsy of small bowel (except ileum) using an endoscope | 13 | $920 | $71 |
2013: 13 services
| Imaging of digestive tract done from the inside of the digestive tract | 53 | $46,712 | $865 |
| New patient visit (45+ min) | 198 | $25,262 | $128 |
| Biopsy of large bowel using a flexible endoscope | 128 | $23,606 | $180 |
| Return visit (30+ min) | 142 | $17,384 | $87 |
| Destruction of internal hemorrhoids using heat | 24 | $11,750 | $184 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 108 | $11,295 | $100 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 39 | $8,785 | $89 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 27 | $6,429 | $230 |
| Diagnostic exam of large bowel using a flexible endoscope | 33 | $5,859 | $178 |
| New patient visit (60+ min) | 37 | $5,746 | $155 |
| Long return visit (40+ min) | 36 | $4,731 | $118 |
| Biopsy of small bowel (except ileum) using an endoscope | 28 | $2,764 | $99 |
| Short return visit (20+ min) | 20 | $1,662 | $59 |
Medicaid work
$984,236 in 2024
Medicaid paid $984,236 for 2,191 billed services this clinician did in 2024, up to 43 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SMALL BOWEL ENDOSCOPY/BIOPSY | 470 | $298,862 |
| COLONOSCOPY FLX W/ENDOSCOPIC MUCOSAL RESECTION | 210 | $194,549 |
| Upper gastrointestinal endoscopy with biopsy | 472 | $182,737 |
| COLONOSCOPY W/LESION REMOVAL | 374 | $179,358 |
| New patient visit (45+ min) | 365 | $65,990 |
| COLONOSCOPY AND BIOPSY | 119 | $38,947 |
| Return visit (30+ min) | 181 | $23,793 |
| 2024 | 2,191 | 7 | 43 | $984,236 |
| 2023 | 941 | 7 | 24 | $308,438 |
| 2022 | 208 | 5 | 21 | $52,930 |
| 2021 | 171 | 4 | 18 | $5,516 |
| 2020 | 60 | 2 | 18 | $2,147 |
See the largest Medicaid services in earlier years
2023
| COLONOSCOPY FLX W/ENDOSCOPIC MUCOSAL RESECTION | 110 | $77,293 |
| SMALL BOWEL ENDOSCOPY/BIOPSY | 130 | $58,528 |
| COLONOSCOPY W/LESION REMOVAL | 144 | $51,674 |
| Upper gastrointestinal endoscopy with biopsy | 144 | $44,068 |
| New patient visit (45+ min) | 219 | $34,334 |
| COLONOSCOPY AND BIOPSY | 111 | $32,641 |
| Return visit (30+ min) | 83 | $9,901 |
2022
| SMALL BOWEL ENDOSCOPY/BIOPSY | 38 | $17,632 |
| New patient visit (45+ min) | 94 | $15,930 |
| Upper gastrointestinal endoscopy with biopsy | 38 | $11,559 |
| COLONOSCOPY AND BIOPSY | 25 | $4,317 |
| COLONOSCOPY W/LESION REMOVAL | 13 | $3,493 |
2021
| New patient visit (45+ min) | 12 | $2,034 |
| SMALL BOWEL ENDOSCOPY/BIOPSY | 12 | $1,876 |
| Upper gastrointestinal endoscopy with biopsy | 12 | $1,605 |
| Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 135 | $0 |
2020
| New patient visit (45+ min) | 12 | $2,147 |
| Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 48 | $0 |
Drugs they prescribed that Part D paid
$424,986
Pharmacies billed $424,986 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,834) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
1,368 generic and 466 brand-name prescriptions · $424,986 in drug cost · 66 antibiotic prescriptions to 43 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Linzess | 94 | $107,600 | $1,145 |
| Creon | 22 | $83,311 | $3,787 |
| Sod Sulf-Potass Sulf-Mag Sulf | 530 | $35,443 | $67 |
| Viberzi | 11 | $19,177 | $1,743 |
| Alosetron | 22 | $17,419 | $792 |
See all 22 drugs
| Linzess | 94 | $107,600 | $1,145 |
| Creon | 22 | $83,311 | $3,787 |
| Sod Sulf-Potass Sulf-Mag Sulf | 530 | $35,443 | $67 |
| Viberzi | 11 | $19,177 | $1,743 |
| Alosetron | 22 | $17,419 | $792 |
| Motegrity | 13 | $11,386 | $876 |
| Pantoprazole | 477 | $7,407 | $16 |
| Mesalamine | 19 | $6,206 | $327 |
| Dexlansoprazole Dr | 18 | $5,676 | $315 |
| Sutab | 32 | $5,102 | $159 |
| Sucralfate | 80 | $4,664 | $58 |
| Ursodiol | 19 | $3,651 | $192 |
| Lubiprostone | 21 | $2,689 | $128 |
| Dicyclomine | 75 | $1,699 | $23 |
| Peg 3350-Electrolyte | 64 | $1,634 | $26 |
| Famotidine | 70 | $1,177 | $17 |
| Omeprazole | 49 | $1,016 | $21 |
| Budesonide Dr | 11 | $838 | $76 |
| Neomycin Sulfate | 17 | $277 | $16 |
| Levofloxacin | 35 | $158 | $5 |
| Ondansetron | 12 | $116 | $10 |
| Metoclopramide | 22 | $90 | $4 |
Year by year
| 2024 | 1,834 | 822 | 0% (0) | 25% | $424,986 |
| 2023 | 1,652 | 656 | 0% (0) | 26% | $506,377 |
| 2022 | 1,490 | 557 | 0% (0) | 34% | $474,151 |
| 2021 | 1,386 | 475 | 0% (0) | 30% | $384,307 |
| 2020 | 1,380 | 520 | None | 32% | $301,276 |
| 2019 | 1,526 | 564 | 0% (0) | 31% | $492,656 |
| 2018 | 1,640 | 581 | 0% (0) | 37% | $313,226 |
| 2017 | 1,482 | 528 | 0% (0) | 45% | $352,015 |
| 2016 | 1,438 | 435 | 0% (0) | 45% | $418,614 |
| 2015 | 1,463 | 430 | 0% (0) | 49% | $359,206 |
| 2014 | 1,104 | 355 | None | 50% | $214,257 |
| 2013 | 715 | 222 | 0% (0) | 43% | $113,546 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 21 drugs
| Creon | 49 | $157,214 | $3,208 |
| Linzess | 75 | $84,884 | $1,132 |
| Alosetron | 18 | $44,975 | $2,499 |
| Mesalamine | 28 | $28,856 | $1,031 |
| Sod Sulf-Potass Sulf-Mag Sulf | 287 | $22,611 | $79 |
| Dexlansoprazole Dr | 22 | $11,324 | $515 |
| Pantoprazole | 482 | $10,288 | $21 |
| Ursodiol | 11 | $5,693 | $518 |
| Sutab | 27 | $4,572 | $169 |
| Sucralfate | 78 | $4,249 | $54 |
| Budesonide Dr | 26 | $2,560 | $98 |
| Suprep | 24 | $2,550 | $106 |
| Prevalite | 18 | $1,637 | $91 |
| Omeprazole | 72 | $1,450 | $20 |
| Peg 3350-Electrolyte | 62 | $1,446 | $23 |
| Dicyclomine | 74 | $1,376 | $19 |
| Famotidine | 56 | $1,360 | $24 |
| Gavilyte-C | 21 | $344 | $16 |
| Levofloxacin | 33 | $272 | $8 |
| Ondansetron | 17 | $199 | $12 |
| Metoclopramide | 11 | $98 | $9 |
2022: 23 drugs
| Creon | 38 | $127,182 | $3,347 |
| Linzess | 82 | $83,982 | $1,024 |
| Alosetron | 28 | $67,340 | $2,405 |
| Mesalamine | 18 | $24,008 | $1,334 |
| Suprep | 155 | $17,680 | $114 |
| Budesonide Ec | 16 | $13,628 | $852 |
| Dexilant | 18 | $9,309 | $517 |
| Pantoprazole | 428 | $9,198 | $21 |
| Sutab | 57 | $9,148 | $160 |
| Movantik | 17 | $8,103 | $477 |
| Dexlansoprazole Dr | 13 | $5,497 | $423 |
| Budesonide Dr | 24 | $4,784 | $199 |
| Prevalite | 23 | $4,112 | $179 |
| Sod Sulf-Potass Sulf-Mag Sulf | 48 | $3,934 | $82 |
| Sucralfate | 47 | $2,107 | $45 |
| Dicyclomine | 76 | $1,658 | $22 |
| Omeprazole | 71 | $1,279 | $18 |
| Famotidine | 48 | $1,174 | $24 |
| Ondansetron | 14 | $726 | $52 |
| Peg 3350-Electrolyte | 34 | $599 | $18 |
| Levofloxacin | 43 | $388 | $9 |
| Neomycin Sulfate | 22 | $371 | $17 |
| Promethazine | 11 | $82 | $7 |
2021: 23 drugs
| Linzess | 70 | $58,315 | $833 |
| Alosetron | 20 | $45,380 | $2,269 |
| Xifaxan | 15 | $40,041 | $2,669 |
| Creon | 12 | $28,052 | $2,338 |
| Viberzi | 14 | $19,923 | $1,423 |
| Suprep | 158 | $17,645 | $112 |
| Pantoprazole | 456 | $11,401 | $25 |
| Dexilant | 24 | $10,918 | $455 |
| Ursodiol | 21 | $9,793 | $466 |
| Movantik | 15 | $5,571 | $371 |
| Sutab | 34 | $5,277 | $155 |
| Prevalite | 16 | $3,756 | $235 |
| Budesonide Ec | 11 | $3,645 | $331 |
| Budesonide Dr | 11 | $3,491 | $317 |
| Omeprazole | 88 | $2,327 | $26 |
| Dicyclomine | 87 | $1,838 | $21 |
| Sucralfate | 41 | $1,799 | $44 |
| Famotidine | 60 | $1,784 | $30 |
| Ondansetron | 23 | $702 | $31 |
| Neomycin Sulfate | 21 | $394 | $19 |
| Levofloxacin | 31 | $191 | $6 |
| Peg 3350-Electrolyte | 13 | $166 | $13 |
| Metoclopramide | 11 | $82 | $7 |
2020: 18 drugs
| Linzess | 49 | $41,475 | $846 |
| Alinia | 16 | $40,073 | $2,505 |
| Viberzi | 18 | $29,816 | $1,656 |
| Suprep | 212 | $22,456 | $106 |
| Mesalamine | 11 | $15,910 | $1,446 |
| Dexilant | 23 | $10,969 | $477 |
| Pantoprazole | 488 | $10,837 | $22 |
| Ursodiol | 15 | $9,150 | $610 |
| Budesonide Ec | 22 | $8,659 | $394 |
| Clenpiq | 37 | $5,630 | $152 |
| Sucralfate | 55 | $3,638 | $66 |
| Omeprazole | 120 | $2,740 | $23 |
| Famotidine | 43 | $1,468 | $34 |
| Dicyclomine | 44 | $904 | $21 |
| Peg 3350-Electrolyte | 16 | $275 | $17 |
| Neomycin Sulfate | 16 | $253 | $16 |
| Metoclopramide | 14 | $194 | $14 |
| Levofloxacin | 17 | $188 | $11 |
2019: 20 drugs
| Linzess | 57 | $44,005 | $772 |
| Viberzi | 23 | $35,299 | $1,535 |
| Alinia | 12 | $25,920 | $2,160 |
| Suprep | 249 | $25,071 | $101 |
| Xifaxan | 15 | $21,585 | $1,439 |
| Dexilant | 31 | $15,763 | $508 |
| Mesalamine | 11 | $13,560 | $1,233 |
| Amitiza | 11 | $10,541 | $958 |
| Pantoprazole | 493 | $8,886 | $18 |
| Ursodiol | 21 | $6,859 | $327 |
| Omeprazole | 185 | $3,059 | $17 |
| Prevalite | 12 | $2,187 | $182 |
| Ranitidine | 50 | $1,903 | $38 |
| Sucralfate | 48 | $1,311 | $27 |
| Diphenoxylate-Atropine | 13 | $764 | $59 |
| Dicyclomine | 45 | $693 | $15 |
| Famotidine | 39 | $421 | $11 |
| Peg 3350-Electrolyte | 14 | $264 | $19 |
| Metoclopramide | 22 | $156 | $7 |
| Levofloxacin | 14 | $138 | $10 |
2018: 21 drugs
| Linzess | 108 | $78,717 | $729 |
| Alinia | 44 | $65,330 | $1,485 |
| Viberzi | 24 | $42,794 | $1,783 |
| Suprep | 318 | $29,529 | $93 |
| Dexilant | 47 | $21,196 | $451 |
| Amitiza | 14 | $11,156 | $797 |
| Mesalamine | 12 | $7,966 | $664 |
| Pantoprazole | 406 | $6,821 | $17 |
| Ursodiol | 16 | $6,251 | $391 |
| Prevalite | 22 | $3,447 | $157 |
| Omeprazole | 214 | $2,827 | $13 |
| Ranitidine | 77 | $2,471 | $32 |
| Sucralfate | 64 | $1,282 | $20 |
| Cholestyramine Light | 12 | $747 | $62 |
| Dicyclomine | 47 | $496 | $11 |
| Metoclopramide | 36 | $304 | $8 |
| Levofloxacin | 22 | $263 | $12 |
| Peg 3350-Electrolyte | 11 | $161 | $15 |
| Buspirone | 12 | $156 | $13 |
| Prednisone | 11 | $70 | $6 |
| Spironolactone | 12 | $12 | $1 |
2017: 16 drugs
| Linzess | 121 | $83,585 | $691 |
| Alinia | 41 | $58,095 | $1,417 |
| Humira | 12 | $54,314 | $4,526 |
| Dexilant | 82 | $26,634 | $325 |
| Suprep | 296 | $25,915 | $88 |
| Amitiza | 27 | $19,178 | $710 |
| Lialda | 11 | $10,817 | $983 |
| Pantoprazole | 258 | $3,723 | $14 |
| Omeprazole | 214 | $2,835 | $13 |
| Ranitidine | 110 | $2,539 | $23 |
| Prevalite | 13 | $1,423 | $109 |
| Sucralfate | 41 | $946 | $23 |
| Dicyclomine | 39 | $298 | $8 |
| Metoclopramide | 14 | $143 | $10 |
| Levofloxacin | 16 | $107 | $7 |
| Furosemide | 12 | $35 | $3 |
2016: 17 drugs
| Humira | 14 | $86,676 | $6,191 |
| Dexilant | 139 | $42,258 | $304 |
| Linzess | 92 | $40,368 | $439 |
| Alinia | 32 | $29,278 | $915 |
| Amitiza | 42 | $19,496 | $464 |
| Suprep | 197 | $16,331 | $83 |
| Delzicol | 11 | $6,012 | $547 |
| Pantoprazole | 314 | $4,163 | $13 |
| Prevalite | 19 | $2,259 | $119 |
| Omeprazole | 175 | $2,156 | $12 |
| Cholestyramine Light | 11 | $1,448 | $132 |
| Ranitidine | 47 | $1,258 | $27 |
| Sucralfate | 52 | $1,079 | $21 |
| Methotrexate | 14 | $510 | $36 |
| Dicyclomine | 41 | $304 | $7 |
| Levofloxacin | 17 | $289 | $17 |
| Metoclopramide | 15 | $106 | $7 |
2015: 19 drugs
| Humira | 20 | $78,182 | $3,909 |
| Dexilant | 139 | $36,891 | $265 |
| Linzess | 107 | $32,383 | $303 |
| Amitiza | 60 | $21,804 | $363 |
| Suprep | 204 | $16,556 | $81 |
| Alinia | 76 | $16,182 | $213 |
| Pantoprazole | 243 | $3,533 | $15 |
| Omeprazole | 224 | $2,521 | $11 |
| Prevalite | 20 | $1,852 | $93 |
| Polyethylene Glycol 3350 | 24 | $1,580 | $66 |
| Cholestyramine Light | 11 | $1,370 | $125 |
| Methotrexate | 20 | $1,229 | $61 |
| Rabeprazole | 19 | $1,198 | $63 |
| Sucralfate | 43 | $1,042 | $24 |
| Dicyclomine | 41 | $299 | $7 |
| Levofloxacin | 28 | $283 | $10 |
| Ranitidine | 19 | $200 | $11 |
| Prednisone | 12 | $103 | $9 |
| Metoclopramide | 13 | $80 | $6 |
2014: 16 drugs
| Humira | 12 | $65,059 | $5,422 |
| Dexilant | 91 | $22,366 | $246 |
| Linzess | 71 | $19,016 | $268 |
| Amitiza | 45 | $15,972 | $355 |
| Suprep | 184 | $14,355 | $78 |
| Nexium | 22 | $8,697 | $395 |
| Alinia | 32 | $6,047 | $189 |
| Omeprazole | 235 | $3,110 | $13 |
| Pantoprazole | 104 | $1,437 | $14 |
| Sucralfate | 29 | $912 | $31 |
| Methotrexate | 14 | $889 | $64 |
| Rabeprazole | 15 | $791 | $53 |
| Levofloxacin | 27 | $439 | $16 |
| Prednisone | 16 | $221 | $14 |
| Dicyclomine | 28 | $194 | $7 |
| Amitriptyline | 11 | $72 | $7 |
2013: 15 drugs
| Dexilant | 85 | $16,107 | $189 |
| Amitiza | 48 | $13,317 | $277 |
| Nexium | 15 | $5,796 | $386 |
| Linzess | 19 | $5,214 | $274 |
| Suprep | 50 | $3,600 | $72 |
| Omeprazole | 179 | $2,568 | $14 |
| Cholestyramine | 11 | $1,232 | $112 |
| Polyethylene Glycol 3350 | 13 | $1,005 | $77 |
| Sucralfate | 29 | $887 | $31 |
| Venlafaxine Hcl Er | 20 | $538 | $27 |
| Pantoprazole | 40 | $536 | $13 |
| Peg-3350 With Flavor Packs | 25 | $452 | $18 |
| Gavilyte-N | 12 | $218 | $18 |
| Levofloxacin | 12 | $196 | $16 |
| Dicyclomine | 20 | $154 | $8 |
Money from drug and device companies
$872 in 2025
| 2025 | 11 | 60 | None | $872 |
| 2024 | 7 | 74 | None | $1,117 |
| 2023 | 11 | 80 | None | $1,089 |
| 2022 | 9 | 72 | None | $860 |
| 2021 | 5 | 40 | None | $420 |
| 2020 | 9 | 51 | None | $614 |
| 2019 | 8 | 95 | None | $1,347 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Creon | $427 | 42 payments
|
| Janssen Biotech | Tremfya | $92 | 4 payments
|
| Pfizer | Xeljanz | $80 | 3 payments
|
| Madrigal Pharmaceuticals | Rezdiffra | $72 | 3 payments
|
| Aimmune Therapeutics | Zenpep | $62 | 2 payments
|
| Exelixis | Cabometyx | $33 | 1 payment
|
See all 60 published payments
| Abbvie | Meals · 2025-12-16 | Linzess | $11 |
| Madrigal Pharmaceuticals | Meals · 2025-12-10 | Rezdiffra | $32 |
| Azurity Pharmaceuticals | Meals · 2025-12-01 | Sutab | $21 |
| Madrigal Pharmaceuticals | Meals · 2025-11-26 | Rezdiffra | $20 |
| Abbvie | Meals · 2025-11-04 | Creon | $15 |
| Aimmune Therapeutics | Meals · 2025-11-03 | Zenpep | $27 |
| Abbvie | Meals · 2025-10-14 | Creon | $11 |
| Braintree Laboratories | Meals · 2025-10-13 | Suflave | $21 |
| Janssen Biotech | Meals · 2025-10-13 | Tremfya | $19 |
| Abbvie | Meals · 2025-10-06 | Linzess | $26 |
| Abbvie | Meals · 2025-09-30 | Creon | $10 |
| Abbvie | Meals · 2025-09-23 | Creon | $10 |
| Abbvie | Meals · 2025-09-16 | Creon | $9 |
| Abbvie | Meals · 2025-09-09 | Creon | $10 |
| Exelixis | Meals · 2025-09-02 | Cabometyx | $33 |
| Abbvie | Meals · 2025-08-26 | Creon | $7 |
| Abbvie | Meals · 2025-08-26 | Creon | $10 |
| Abbvie | Meals · 2025-08-19 | Creon | $12 |
| Abbvie | Meals · 2025-08-12 | Creon | $4 |
| Abbvie | Meals · 2025-08-12 | Creon | $9 |
| Abbvie | Meals · 2025-08-11 | Rinvoq | $29 |
| Abbvie | Meals · 2025-08-05 | Creon | $6 |
| Abbvie | Meals · 2025-08-05 | Creon | $4 |
| Abbvie | Meals · 2025-07-29 | Creon | $9 |
| Abbvie | Meals · 2025-07-15 | Creon | $9 |
| Abbvie | Meals · 2025-07-09 | Creon | $8 |
| Abbvie | Meals · 2025-07-08 | Creon | $6 |
| Lilly USA | Meals · 2025-07-07 | Omvoh | $22 |
| Pfizer | Meals · 2025-06-30 | Xeljanz | $30 |
| Abbvie | Meals · 2025-06-23 | Rinvoq | $19 |
| Abbvie | Meals · 2025-06-03 | Creon | $12 |
| Abbvie | Meals · 2025-06-03 | Rinvoq | $19 |
| Abbvie | Meals · 2025-05-27 | Creon | $11 |
| Abbvie | Meals · 2025-05-20 | Creon | $11 |
| Abbvie | Meals · 2025-05-13 | Creon | $3 |
| Abbvie | Meals · 2025-05-13 | Creon | $9 |
| McKesson Medical-Surgical | Meals · 2025-05-07 | None | $18 |
| Abbvie | Meals · 2025-04-30 | Creon | $2 |
| Abbvie | Meals · 2025-04-29 | Creon | $6 |
| Abbvie | Meals · 2025-04-29 | Creon | $5 |
| Janssen Biotech | Meals · 2025-04-28 | Tremfya | $26 |
| Ardelyx | Meals · 2025-04-21 | Ibsrela | $24 |
| Abbvie | Meals · 2025-04-15 | Rinvoq | $14 |
| Abbvie | Meals · 2025-04-15 | Creon | $11 |
| Abbvie | Meals · 2025-04-08 | Creon | $10 |
| Abbvie | Meals · 2025-04-02 | Linzess | $12 |
| Abbvie | Meals · 2025-03-31 | Creon | $10 |
| Janssen Biotech | Meals · 2025-03-24 | Tremfya | $28 |
| Abbvie | Meals · 2025-03-10 | Creon | $12 |
| Madrigal Pharmaceuticals | Meals · 2025-03-10 | Rezdiffra | $21 |
| Abbvie | Meals · 2025-03-04 | Linzess | $8 |
| Abbvie | Meals · 2025-02-24 | Creon | $8 |
| Pfizer | Meals · 2025-02-24 | Xeljanz | $27 |
| Abbvie | Meals · 2025-02-04 | Creon | $10 |
| Janssen Biotech | Meals · 2025-01-27 | Tremfya | $18 |
| Abbvie | Meals · 2025-01-23 | Skyrizi | $5 |
| Aimmune Therapeutics | Meals · 2025-01-20 | Zenpep | $35 |
| Abbvie | Meals · 2025-01-13 | Creon | $8 |
| Pfizer | Meals · 2025-01-13 | Xeljanz | $23 |
| Abbvie | Meals · 2025-01-07 | Creon | $9 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,117
| Abbvie | Creon | $480 | 44 payments
|
| Pfizer | Xeljanz | $273 | 10 payments
|
| Janssen Biotech | Stelara | $218 | 11 payments
|
| Braintree Laboratories | Sutab | $82 | 5 payments
|
| Regeneron Healthcare Solutions | Dupixent | $28 | 2 payments
|
| Madrigal Pharmaceuticals | Resmetirom | $19 | 1 payment
|
| Intercept Pharmaceuticals | Ocaliva | $18 | 1 payment
|
2023: $1,089
| AbbVie | Viberzi | $231 | 23 payments
|
| Celgene | Zeposia | $188 | 22 payments
|
| Braintree Laboratories | Sutab | $143 | 9 payments
|
| Genzyme | Dupixent | $129 | 8 payments
|
| Janssen Biotech | Remicade | $126 | 5 payments
|
| Nestle Healthcare Nutrition | Zenpep | $87 | 4 payments
|
| Pfizer | Xeljanz | $57 | 2 payments
|
| Intercept Pharmaceuticals | Ocaliva | $50 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $36 | 1 payment
|
| Ardelyx | Ibsrela | $27 | 2 payments
|
| QOL Medical | Sucraid | $15 | 1 payment
|
2022: $860
| Abbvie | Linzess | $393 | 39 payments
|
| Janssen Biotech | Stelara | $152 | 7 payments
|
| Celgene | Zeposia | $133 | 13 payments
|
| Ardelyx | Ibsrela | $91 | 7 payments
|
| Merck Sharp & Dohme | Dificid | $36 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $17 | 1 payment
|
| Pfizer | Xeljanz | $14 | 1 payment
|
| Braintree Laboratories | Sutab | $12 | 1 payment
|
| Digestive Care | Pertzye | $12 | 1 payment
|
2021: $420
| AbbVie | Linzess | $317 | 33 payments
|
| Braintree Laboratories | Sutab | $52 | 4 payments
|
| Pfizer | Xeljanz | $25 | 1 payment
|
| Daiichi Sankyo | Injectafer | $14 | 1 payment
|
| Ferring Pharmaceuticals | Cimzia | $11 | 1 payment
|
2020: $614
| Ferring Pharmaceuticals | Cimzia | $144 | 19 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Plenvu | $142 | 12 payments
|
| Braintree Laboratories | Suprep Bowel Prep | $132 | 10 payments
|
| AbbVie | Linzess | $65 | 4 payments
|
| Janssen Biotech | Stelara | $38 | 2 payments
|
| Pfizer | Xeljanz | $36 | 1 payment
|
| Boston Scientific | Epic Vascular | $23 | 1 payment
|
| Nestle HealthCare Nutrition | Zenpep | $21 | 1 payment
|
| Alfasigma USA | Zelnorm | $13 | 1 payment
|
2019: $1,347
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $473 | 42 payments
|
| Braintree Laboratories | Suprep Bowel Prep | $344 | 29 payments
|
| Medtronic USA | Interstim Icon | $160 | 1 payment
|
| QOL Medical | Sucraid | $95 | 13 payments
|
| Daiichi Sankyo | Injectafer | $84 | 4 payments
|
| Pfizer | Xeljanz | $82 | 4 payments
|
| Nevro | Senza Spinal Cord Stimulation System | $81 | 1 payment
|
| Boston Scientific | General Atherectomy | $29 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1093893091
- Licence
- CA A78375California A78375: Current · expires 2027-05-31
- Trained
- Virginia Commonwealth University, School of Medicine, 2000 · 26 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 174400000X (174400000X)
- Mailing address
- 2222 East St Ste 340, Concord, CA, 94520
- NPI first listed
- 2006-11-01
- NPI last updated
- 2026-07-20
- NPI record certified
- 2026-07-20
This is when the NPI record was last certified, not a medical board exam.